KI NMA collaborative grants 2021
The KI Network Medicine Global Alliance (KI NMA) steering group is pleased to announce the availability of limited competitive funds for grant applications by faculty, staff and/or trainees to conduct collaborative interactions within the Network Medicine Institute and Global Alliance. The grants are to be used as collaborative grants aiming to start and sustain collaborations within the field of network medicine. NB! Extended deadline until November 18, 2021.
This call is closed.
Funding can be used for starting a collaboration within network medicine, analysis for ongoing collaborative projects or travel to other lab (with regards to travel or other restrictions due to the current Covid-19 situation). The KI NMA collaborative grant may include support for transportation and accommodation at the host site (which should be an institutional member of the Network Medicine Institute and Global Alliance) for the proposed period of interaction. The funds may also be used for material etc. used for preliminary data collection in a new or existing collaborative project.
It is also possible to apply for funds to write a larger grant proposal in the field of network medicine together with one or several partners in the Network Medicine Institute and Global Alliance and/or with one or several partners at KI, coming from different disciplines and departments, or with partners from other Swedish institutions. The grant should target major granting agencies (e.g. EC, NIH, SSF, STINT, EIT Health). Applications including a partner from the Network Medicine Institute and Global Alliance will be prioritized based on the evaluation criteria described below.
The maximal amount awarded will be 70 000 SEK.
Grants will be awarded on the basis of:
- Project description, quality, feasibility and synergy
- Prospect for long-term collaborative research, education or innovation
- Accordance to the KI long-term goals and strategy for the collaboration within the Network Medicine Institute and Global Alliance
International partners of the NMA
A condition for receiving the KI NMA collaborative grant is collaboration within, but not limited to, the NMA. The list of international partners can be found at: https://www.network-medicine.org/members.
Assessment of applications
The applications will be assessed by an evaluation committee composed of members from the KI NMA steering group and external experts. The Internationalisation Advisory Council will thereafter decide which applications will be funded in December 2021.
All applications are assessed on the basis of the following three criteria
- scientific quality and potential of the proposed project
- project feasibility
- prospect for long-term collaborative research, education or innovation within the Network Medicine Institute and Global Alliance
Weighting of the criteria is: 1 + 1 + 1
Scientific quality and potential of the proposed project
- Is the project original, innovative and challenging of reigning opinions or praxis?
- Does it include an innovative hypothesis, or does it seek to resolve important obstacles for continued progresses within the research area?
- Does the project involve new ideas, therapies or interpretations?
- If the project aims are achieved, would that significantly enrich knowledge in the particular research field and knowledge of health, disease and healthcare?
- Does the project have clinical relevance, and would the likely results be clinically implementable in the future?
- Are the total financial resources realistic in relation to the scope of the collaboration/grant application?
- Is there sufficient methodological competence to implement the project in the manner described?
- Are there other experiences that in combination with the applicants’ various competencies strengthen the project feasibility?
- Are materials, patients and methods well-chosen and adjusted for the hypothesis?
- What are the strengths and weakness of the chosen approach?
- Is the project ethically sound?
Prospect for long-term collaborative research, education or innovation within the Network Medicine Institute and Global Alliance
- Is the research plan consistent with the expertise, research focus and equipment of collaborating parties?
- Is there a demonstrated division of tasks and activities between the collaborating labs?
- Do factors exist that could emphasize the coherence of the proposed project, such as prior collaborative efforts as evidenced by common publications and/or grants?
- Does the application make clear that the achievement of the project goals is dependent on the participation and interaction of both supervisors and on their complementary skills and knowledge?
5 points = outstanding
4 points = excellent
3 points = very good
2 points = good
1 points = insufficient
Written feedback to applicants
There will be no written feedback to the applicants. All applicants will receive an e-mail with a decision.
Application process and deadline
The deadline for grant proposals has been prolonged to November 18 2021. Proposals must be submitted via email to email@example.com. Proposals submitted after the deadline will not be considered. The application should be sent in as a single Word or PDF file, be no more than four pages and should reflect the criteria used for assessment (and include a short budget plan. Please mark the application with Dnr 2-3975/2021. CV for main applicant/applicants is not included in the four page limit and can be sent as a seperate file.
Decision will be communicated no later December 2021 and grant can be used for one year after issue.
For any questions regarding the application please contact firstname.lastname@example.org and for more information about KI NMA visit https://ki.se/en/collaboration/the-network-medicine-alliance and read more about our partners and the Network Medicine Institute and Global Alliance at https://www.network-medicine.org/.